SCHEMBL17293172

SCHEMBL17293172

FC(F)(F)c1cc(C2=CCc3ccccc32)cc(C(F)(F)F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.41
HTR7 P34969 2/20 0.41
TACR1 P25103 5/20 0.39
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP2C9 P11712 1/20 0.34
HPGD P15428 1/20 0.34
CYP2C19 P33261 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PARP1 P09874 1/20 0.33
GPR3 P46089 1/20 0.33
CYP17A1 P05093 1/20 0.33
TSHR P16473 1/20 0.33
RXRA P19793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18774721 0.90 HTR1A (0.37) HTR1AHTR7TACR1ALDH1A1MEN1
SCHEMBL18763979 0.85 NPC1 (0.36) ALDH1A1CYP1A2CYP2C9CYP2C19TSHR
SCHEMBL170839 0.74 ALDH1A1 (0.39) ALDH1A1KMT2AHPGDSMN1; SMN2CYP17A1
SCHEMBL29598333 0.74 ALDH1A1 (0.39) ALDH1A1KMT2AHPGDSMN1; SMN2CYP17A1
SCHEMBL9873789 0.74 MAPT (0.39) HTR1AALDH1A1MEN1KMT2APOLB
SCHEMBL28134284 0.74 HSD11B1 (0.40) ALDH1A1CNR2CYP1A2HPGDCYP2C19
SCHEMBL9441562 0.72 CYP3A4 (0.54) HTR1AHTR7POLBSMN1; SMN2CYP17A1
SCHEMBL18763972 0.71 S1PR1 (0.38) ALDH1A1MEN1KMT2ATSHRCYP3A4
SCHEMBL30143246 0.71 S1PR1 (0.38) ALDH1A1MEN1KMT2ATSHRCYP3A4
SCHEMBL8657090 0.70 MAOA (0.36) ALDH1A1KMT2ACYP1A2CYP2C19PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148937-B1 METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME BRIDGESTONE CORP (JP) 2019-09-18 EP disclosed
US-10017595-B2 Metallic complex catalyst and polymerization methods employing same BRIDGESTONE CORPORATION (JP) 2018-07-10 US disclosed
US-10017595-B2 Metallic complex catalyst and polymerization methods employing same BRIDGESTONE CORPORATION (JP) 2018-07-10 US disclosed
US-20170114171-A1 Metallic Complex Catalyst And Polymerization Methods Employing Same BRIDGESTONE CORPORATION (JP) 2017-04-27 US disclosed
US-20170114171-A1 Metallic Complex Catalyst And Polymerization Methods Employing Same BRIDGESTONE CORPORATION (JP) 2017-04-27 US disclosed
EP-3148937-A1 METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME Bridgestone Corporation (JP) 2017-04-05 EP disclosed
WO-2015183770-A1 METALLIC COMPLEX CATALYST AND POLYMERIZATION METHODS EMPLOYING SAME BRIDGESTONE CORPORATION (JP) 2015-12-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170114171-A1 Metallic Complex Catalyst And Polymerization Methods Employing Same C5, C1S, C9 HTR1A 2561/4885HTR7 2423/4885TACR1 3084/4885
US-10017595-B2 Metallic complex catalyst and polymerization methods employing same C5, C1S, C9 HTR1A 2561/4885HTR7 2423/4885TACR1 3084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.